Current research into the drug are demonstrating promising outcomes regarding body composition . Initially intended for addressing type 2 diabetes , this GLP-1 receptor agonist has shown considerable https://bookmarknap.com/story12053810/semaglutide-research-unlocking-new-weight-loss-opportunities